Enigma Diagnostics inked license agreements with Applera covering a real-time instrument patent and an application kit.

The real-time instrument patent license deal covers Enigma’s current and pipeline instrument platforms of fully automated, real-time thermal cyclers across the commercial market sectors of research and applied markets. This agreement also provides Enigma with an option for a license in clinical diagnostics.

The application kit license agreement covers a portfolio of patents covering reverse transcription-based methods, real-time PCR detection process, and 5′ nuclease assays and compositions for use in fields excluding human diagnostics.

Next articleUMMZ Periodical Cicada Page